Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Fosun International Limited    0656   HK0656038673

FOSUN INTERNATIONAL LIMITED

(0656)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Fosun International : ANNUAL GENERAL MEETING FORM OF PROXY

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2019 | 06:53am EDT

Annual General Meeting

Form of Proxy

Form of proxy for use at the Annual General Meeting to be held on Wednesday, 5 June 2019

I/We,(note 1)

of,

being registered holder(s) of

shares(note 2) of the issued shares of Fosun International Limited (the "Company"),

HEREBY APPOINT(note 3) the Chairman of the Meeting or

of

or failing him

of

as my/our proxy/proxies to attend and vote for me/us and on my/our behalf at the annual general meeting (the "Meeting") of the Company to be held at Grand Ballroom, 3/F, Wanda Reign on the Bund, 538 Zhong Shan Dong Er Road, Huangpu District, Shanghai, China and Grand Ballroom 1 & 2, Level B, Hong Kong Ocean Park Marriott Hotel, 180 Wong Chuk Hang Road, Aberdeen, Hong Kong concurrently by video conference at 10 a.m. on Wednesday, 5 June 2019 for the purpose of considering and, if thought fit, passing the resolutions as set out in the notice convening the Meeting and at the Meeting (and at any adjournment thereof) to vote for me/us in my/our name(s), in respect of the resolutions as hereunder indicated.

RESOLUTIONS

FOR

AGAINST

(Note 4)

(Note 4)

1.

To receive and consider the audited consolidated financial statements and the reports of the board of directors of the Company and of Auditors

for the year ended 31 December 2018.

2.

To declare a final dividend for the year ended 31 December 2018.

3.

(i)

To re-elect Mr. Guo Guangchang as executive director of the Company

(i)

(i)

(ii)

To re-elect Mr. Wang Can as executive director of the Company

(ii)

(ii)

(iii)

To re-elect Mr. Gong Ping as executive director of the Company

(iii)

(iii)

(iv)

To re-elect Mr. David T. Zhang as independent non-executive director of the Company

(iv)

(iv)

(v)

To authorize the board of directors of the Company to fix the remuneration of the directors of the Company.

(v)

(v)

4.

To reappoint Ernst & Young as Auditors and to authorize the board of directors of the Company to fix their remuneration.

5.

To give a general mandate to the directors of the Company to repurchase the shares of the Company not exceeding 10% of the total issued

shares of the Company as at the date of passing of this resolution.

6.

To give a general mandate to the directors of the Company to issue, allot and deal with additional shares of the Company not exceeding 20%

of the total issued shares of the Company as at the date of passing of this resolution.

7.

To extend the general mandate granted to the directors of the Company to issue, allot and deal with additional shares of the Company by the

total shares repurchased by the Company.

8.

To grant an unconditional mandate to the directors of the Company (i) to exercise all the powers of the Company during the relevant period

to grant options under the share option scheme; (ii) to issue and allot shares of the Company as and when any options granted under the share

option scheme and the old share option scheme are exercised during the relevant period; and (iii) at any time after the relevant period, to issue

and allot shares of the Company pursuant to the exercise of share options granted under the share option scheme and the old share option

scheme.

9.

(a)

To approve, confirm and ratify the grant of specific mandate to the directors of the Company regarding the issue and allotment of an

(a)

(a)

aggregate of 5,973,750 new shares ("New Award Shares") to Computershare Hong Kong Trustees Limited to hold on trust for selected

participants who are selected by the board of directors of the Company (the "Selected Participants") for participation in the share

award scheme adopted by the Company on 25 March 2015 (the "Share Award Scheme") (the "Award") and the transactions

contemplated thereunder.

(b)

To approve and confirm the grant of 535,000 award shares pursuant to the Share Award Scheme to Mr. Chen Qiyu.

(b)

(b)

(c)

To approve and confirm the grant of 535,000 award shares pursuant to the Share Award Scheme to Mr. Xu Xiaoliang.

(c)

(c)

(d)

To approve and confirm the grant of 310,000 award shares pursuant to the Share Award Scheme to Mr. Qin Xuetang.

(d)

(d)

(e)

To approve and confirm the grant of 310,000 award shares pursuant to the Share Award Scheme to Mr. Wang Can.

(e)

(e)

(f)

To approve and confirm the grant of 235,000 award shares pursuant to the Share Award Scheme to Mr. Gong Ping.

(f)

(f)

(g)

To approve and confirm the grant of 25,000 award shares pursuant to the Share Award Scheme to Mr. Zhang Shengman.

(g)

(g)

(h)

To approve and confirm the grant of 25,000 award shares pursuant to the Share Award Scheme to Mr. Zhang Huaqiao.

(h)

(h)

(i)

To approve and confirm the grant of 25,000 award shares pursuant to the Share Award Scheme to Mr. David T. Zhang.

(i)

(i)

(j)

To approve and confirm the grant of 25,000 award shares pursuant to the Share Award Scheme to Mr. Yang Chao.

(j)

(j)

(k)

To approve and confirm the grant of 25,000 award shares pursuant to the Share Award Scheme to Dr. Lee Kai-Fu.

(k)

(k)

(l)

To approve and confirm the grant of 255,000 award shares pursuant to the Share Award Scheme to Mr. Zhang Houlin.

(l)

(l)

(m)

To approve and confirm the grant of 115,000 award shares pursuant to the Share Award Scheme to Mr. Li Tao

(m)

(m)

(n)

To approve and confirm the grant of 70,000 award shares pursuant to the Share Award Scheme to Mr. Qian Jiannong

(n)

(n)

(o)

To approve and confirm the grant of 68,000 award shares pursuant to the Share Award Scheme to Ms. Mu Haining

(o)

(o)

(p)

To approve and confirm the grant of 68,000 award shares pursuant to the Share Award Scheme to Mr. Gao Min

(p)

(p)

(q)

To approve and confirm the grant of 60,000 award shares pursuant to the Share Award Scheme to Mr. Zhang Xueqing

(q)

(q)

(r)

To approve and confirm the grant of 35,000 award shares pursuant to the Share Award Scheme to Mr. Xu Lingjiang

(r)

(r)

(s)

To approve and confirm the grant of 35,000 award shares pursuant to the Share Award Scheme to Mr. Pei Yu

(s)

(s)

(t)

To approve and confirm the grant of 3,527,000 award shares pursuant to the Share Award Scheme to the Selected Participants, other

(t)

(t)

than those persons named in resolutions 9(b) - 9(s) above.

(u)

To authorize any one or more of the directors of the Company to do all such acts and things and execute all such documents which

(u)

(u)

he/she/they consider necessary, desirable or expedient for the purpose of, or in connection with, the implementation of and giving effect

to the Award and the transactions contemplated thereunder, including but not limited to the issue and allotment of the New Award

Shares pursuant to the Share Award Scheme.

10.

To approve the adoption of the Yuyuan Tranche II Share Option Incentive Scheme and to authorize the directors of the Company and Yuyuan

to execute all such documents and take all steps as they consider to be necessary, expedient and appropriate to give effect to the scheme.

11.

To approve the adoption of the Gland Pharma Share Option Scheme and to authorize any director of the Company and Gland Pharma to

execute all such documents and take all steps as they consider to be necessary, expedient and appropriate to give effect to the Gland Pharma

Share Option Scheme.

Dated this

day of

2019.

Signature:

(Note 5)

Notes:

1.Full name(s) and address(es) to be inserted in BLOCK CAPITALS.

2.Please insert the number of shares of the Company registered in your name(s). If no number is inserted, this form of proxy will be deemed to relate to all the shares of the Company registered in your name(s).

3.If any proxy other than the Chairman is preferred, strike out the words "Chairman of the Meeting" herein inserted and insert the name and address of the proxy desired in the space provided. Any member of the Company may appoint one or more proxies to attend and vote on his/her behalf at the Meeting provided that if more than one proxy is so appointed, the appointment shall specify the number and class of shares in respect of which each such proxy is so appointed. IF NO NAME IS INSERTED, THE

CHAIRMAN OF THE MEETING WILL ACT AS YOUR PROXY. ANY ALTERATION MADE TO THIS FORM OF PROXY MUST BE INITIALLED BY THE PERSON WHO SIGNS IT.

4.IMPORTANT: IF YOU WISH TO VOTE FOR THE RESOLUTIONS, TICK APPROPRIATE BOXES MARKED "FOR". IF YOU WISH TO VOTE AGAINST THE RESOLUTIONS, TICK APPROPRIATE BOXES MARKED "AGAINST". Failure to complete any or all the boxes will entitle your proxy to cast his votes at his discretion. Your proxy will also be entitled to vote at his discretion on any resolution properly put to the Meeting other than those referred to in the notice convening the Meeting.

5.This form of proxy must be signed by you or your attorney duly authorized in writing or, in the case of a corporation, must be either executed under its common seal or under the hand of an officer or attorney or other person duly authorized.

6.Voting by poll will be conducted at the Meeting. Every member of the Company present in person (in case of a member being a corporation, by its duly authorized representative) or by proxy shall have one vote for every fully paid-up share of which he is the holder.

7.In the case of joint holders, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint holder(s). For this purpose, seniority will be determined by the order in which the names stand in the Register of Members of the Company.

8.To be valid, this form of proxy, together with any power of attorney (if any) or other authority (if any) under which it is signed or a notarially certified copy thereof, must be deposited at the share registrar of the Company, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not less than 48 hours before the time fixed for holding the Meeting or the adjourned Meeting.

9.The proxy needs not be a member of the Company but must attend the Meeting in person to represent you.

10.Completion and delivery of this form of proxy will not preclude you from attending and voting at the Meeting if you so wish.

Disclaimer

Fosun International Limited published this content on 26 April 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 April 2019 10:52:14 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FOSUN INTERNATIONAL LIMITE
08/13FOSUN INTERNATIONAL : Thomas Cook in talks for a fresh £150m cash grab
AQ
08/12Thomas Cook in advanced talks for additional 150 million pound capital
RE
08/12Thomas Cook in advanced talks for additional 150 million pound capital
RE
08/08Stocks: Taste for Fast-Food Shares Increases -- WSJ
DJ
08/07Investors Are Dining Out on Fast-Casual Stocks
DJ
08/05FOSUN INTERNATIONAL : - Guo Guangchang Three Directions is heading towards
AQ
07/29FINTECHS AT THE GATE : online brokers target affluent Brazilians
RE
07/26China moves to regulate 'blind' business expansion of financial holding firms
RE
07/16FOSUN INTERNATIONAL : Billion euro hole found in jeweller Folli's 2017 sales
RE
07/12Thomas Cook enlists China's Fosun to salvage oldest travel firm
RE
More news
Financials (CNY)
Sales 2019 121 B
EBIT 2019 26 052 M
Net income 2019 14 927 M
Debt 2019 79 768 M
Yield 2019 4,27%
P/E ratio 2019 4,72x
P/E ratio 2020 4,37x
EV / Sales2019 1,25x
EV / Sales2020 1,28x
Capitalization 71 322 M
Chart FOSUN INTERNATIONAL LIMITED
Duration : Period :
Fosun International Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FOSUN INTERNATIONAL LIMITE
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Average target price 14,54  CNY
Last Close Price 8,35  CNY
Spread / Highest target 91,7%
Spread / Average Target 74,1%
Spread / Lowest Target 28,8%
EPS Revisions
Managers
NameTitle
Qun Bin Wang Chief Executive Officer & Executive Director
Qi Yu Chen Co-President & Executive Director
Xiao Liang Xu Co-President & Executive Director
Guang Chang Guo Chairman
Can Wang Chief Financial Officer, Executive Director & SVP
Sector and Competitors
1st jan.Capitalization (M$)
FOSUN INTERNATIONAL LIMITED-18.71%10 012
ALLIANZ SE13.42%90 646
CHUBB LTD20.30%70 154
ZURICH INSURANCE GROUP18.42%51 366
MARSH & MCLENNAN COMPANIES22.61%48 940
AMERICAN INTERNATIONAL GROUP INC37.81%46 749